- Easy Tracking In The Watchlist
Weaker technical forecast for Enzon Pharmaceuticals as stock downgraded to Sell Candidate
(Updated on Jul 02, 2026)
No changes to the price of Enzon Pharmaceuticals stock on the last trading day (Thursday, 2nd Jul 2026). During the last trading day the stock fluctuated 0% from a day low at $4.75 to a day high of $4.75. The price has fallen in 7 of the last 10 days and is down by -15.18% for this period.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $4.62 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 85.22% during the next 3 months and, with a 90% probability hold a price between $8.56 and $18.98 at the end of this 3-month period.
ENZN Signals & Forecast
A buy signal was issued from a pivot bottom point on Wednesday, July 01, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Enzon Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.99 and $5.60. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Enzon Pharmaceuticals stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 2.62%
Enzon Pharmaceuticals is oversold on RSI14 (17). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ENZN) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Enzon Pharmaceuticals to open at $4.75, and during the day (based on 14 day Average True Range), to move between $4.66 and $4.84, which gives a possible trading interval of +/-$0.171 (+/-3.67%) up or down from last closing price. If Enzon Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 3.67% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $5.50, some $0.750 (15.79%) from the current price of $4.75, our system finds the risk reward not very attractive.
Is Enzon Pharmaceuticals stock A Buy?
The Enzon Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe Enzon Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-1.616
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on July 6, 2026 - $4.75 ( 0%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ENZN Performance
Trading levels for ENZN
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 4.75 | - |
| R2 | 4.75 | - |
| R1 | 4.75 | - |
| Price | 4.75 | |
| S1 | 4.75 | - |
| S2 | 4.75 | - |
| S3 | 4.75 | - |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 5.85 | 23.16% |
| R2 | 5.75 | 21.05% |
| R1 | 5.50 | 15.79% |
| Price | 4.75 | |
| S1 | 0 | - |
| S2 | 0 | - |
| S3 | 0 | - |
ENZN Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Sep 30, 2019 | Sep 30, 2019 | Oct 15, 2019 | $0.120 | 52.17% |
| 2 | Feb 20, 2019 | Feb 20, 2019 | Feb 20, 2019 | $0.0600 | 26.09% |
| 3 | Sep 29, 2017 | Sep 29, 2017 | Sep 29, 2017 | $0.150 | 62.51% |
| 4 | Dec 13, 2016 | Dec 13, 2016 | Dec 13, 2016 | $0.150 | 44.72% |
| 5 | Dec 30, 2015 | Dec 30, 2015 | Dec 30, 2015 | $0.250 | 36.23% |
FAQ
Click here for our free guide on how to buy Enzon Pharmaceuticals Stock.
Buy ENZN